Investigating a common mold led to the discovery of penicillin, the world’s first widely used antibiotic, which fundamentally changed medicine and added roughly 30 years to the average lifespan in industrialized countries. But penicillin was only the beginning. Research into various mold species has also given us cholesterol-lowering drugs, made organ transplants possible, and created key ingredients used across the food and pharmaceutical industries.
The Mold That Launched Modern Antibiotics
In 1928, Alexander Fleming, a bacteriologist at St. Mary’s Hospital in London, returned from vacation to find something unusual on a petri dish he had left out. A fungus had contaminated the plate, and around it was a clear zone where the bacteria simply hadn’t grown. Fleming isolated the mold, identified it as belonging to the Penicillium genus, and extracted the substance responsible for killing the bacteria. He named it penicillin.
Fleming found that penicillin was effective against staphylococci and other common disease-causing bacteria. But turning a lab observation into a usable medicine took more than a decade. The breakthrough in mass production came in the early 1940s at a research lab in Peoria, Illinois, where scientists discovered that pumping air into deep vats containing corn steep liquor (a byproduct of corn processing) produced far more penicillin than previous methods. After a worldwide search for the most productive mold strain, researchers found it on a moldy cantaloupe from a Peoria grocery store. That cantaloupe strain, once improved, became the foundation for industrial-scale penicillin production.
By the time World War II ended, penicillin was saving thousands of soldiers from infected wounds and bacterial diseases that had killed more troops than combat in every previous war.
A Dramatic Shift in Life Expectancy
Before the 20th century, infectious diseases were the leading cause of death worldwide. Even in industrialized nations, the average life expectancy at birth was just 47 years. Bacterial infections from childbirth, surgery, minor cuts, and common illnesses like pneumonia routinely killed otherwise healthy people.
The antibiotic era, launched by penicillin, changed that picture entirely. In the United States, the leading causes of death shifted from communicable diseases to conditions like heart disease, cancer, and stroke. Average life expectancy at birth rose to nearly 79 years, and the share of the population over 65 grew from 4% to 13%. Penicillin and the antibiotics that followed didn’t accomplish this alone, but they were a central driver. Routine surgeries, cancer treatments, and even dental procedures became far safer once doctors could prevent or treat bacterial infections reliably.
Mold That Made Organ Transplants Possible
In the late 1960s, researchers at a Swiss pharmaceutical company were screening soil samples for interesting biological compounds when they isolated a substance from a mold called Tolypocladium inflatum. That substance, cyclosporine, turned out to have a remarkable property: it could suppress the immune system’s T cells selectively, without wiping out the body’s broader defenses against infection or suppressing bone marrow function.
This was exactly what transplant medicine needed. Before cyclosporine, organ recipients frequently died because their immune systems attacked the transplanted organ, and the drugs used to prevent rejection weakened patients so broadly that infections became deadly. Cyclosporine changed that equation. It was first used in a liver transplant patient in 1980 and received FDA approval in 1983. The drug fundamentally transformed organ transplantation by preventing acute rejection while leaving other immune functions relatively intact. Kidney and liver transplant survival rates improved dramatically, and transplant surgery went from an experimental last resort to a standard, life-saving procedure.
Cholesterol Drugs From a Common Mold
In the late 1970s, Japanese researcher Akira Endo discovered that a compound produced by the mold Aspergillus terreus could block the liver enzyme responsible for producing cholesterol. This compound, lovastatin, became the first in the statin drug class, which is now one of the most widely prescribed medication categories in the world.
Lovastatin works by competitively blocking the specific enzyme your liver uses to manufacture cholesterol. When that enzyme is inhibited, your blood cholesterol levels drop. The discovery that a mold naturally produced this enzyme-blocking compound opened the door to developing an entire family of related drugs. Today, statins are credited with significantly reducing heart attacks and strokes across millions of people globally.
Industrial Uses Beyond Medicine
Not all mold research led to drugs. Aspergillus niger, a black mold found on fruits and vegetables, became the basis for producing citric acid on an industrial scale. Global production reached an estimated 500,000 tons annually, with nearly all of it made through fermentation using this single mold species. Citric acid shows up everywhere: in soft drinks, candy, canned foods, cleaning products, and pharmaceuticals. Before scientists figured out how to use mold for this purpose, citric acid had to be extracted from massive quantities of citrus fruit, making it expensive and limited in supply.
The Challenge of Resistance
The benefits of investigating mold came with a long-term cost. Bacteria evolve, and decades of antibiotic use have driven the emergence of resistant strains. Some pathogens that penicillin once killed easily are now partially or fully resistant. Group B streptococci, for example, show penicillin resistance rates around 28%. The World Health Organization regularly updates its list of priority pathogens that pose the greatest threat due to resistance.
This doesn’t diminish what mold research accomplished. It does mean the work isn’t finished. The same investigative spirit that led Fleming to study a contaminated petri dish continues to drive the search for new antimicrobial compounds, many of them still sourced from fungi and soil organisms. The original act of curiosity about a common mold reshaped medicine, extended human life by decades, and created industries worth billions, all because someone stopped to ask why the bacteria weren’t growing.